Release Date: September 15, 2021
Valid Through: October 31, 2022
Estimated Time to Complete Activity: 60 minutes
This activity was designed to meet the educational needs of physicians, nursing professionals, PAs, rehabilitation therapists, mental health professionals, and other members of the healthcare team involved in the management of patients with MS.
Upon completing this activity, participants should be better able to:
- Examine the comprehensive care model in MS in the context of the clinician’s own practice setting
- Identify members of the comprehensive care team, their unique roles, and the combined contribution of all members in promoting maximal function and wellness in MS
- Realistically examine barriers to the implementation of comprehensive care in real-life practice
- Evaluate strategies to address barriers to the implementation of a comprehensive care model
- Analyze the contribution of rehabilitation professionals in supporting treatment decisions and improving therapy adherence
- Apply expert recommendations to the management of real-life case situations
Patricia Bobryk, MHS, PT, MSCS, ATP
Steamboat Springs, CO
Colleen Harris, MN, NP, MSCN, MSCS
University of Calgary MS Clinic
Accreditation and Credit Designation
In support of improving patient care, The Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Consortium of Multiple Sclerosis Centers designates this enduring material for 1.0 nursing continuing professional development (NPCD) credits.
Physician Assistants (PAs)
The Consortium of Multiple Sclerosis Centers has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until October 31, 2022. PAs should only claim credit commensurate with the extent of their participation.
This activity is awarded 1.0 CE Credits.
As a Jointly Accredited Organization, The Consortium of Multiple Sclerosis Centers is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The CMSC maintains responsibility for this course. Social workers completing this course receive 1.0 continuing education credits.
The Consortium of Multiple Sclerosis Centers is approved by the American Occupational Therapy Association, Inc. (AOTA) as a provider of continuing occupational therapy education. The CMSC designates this activity for 1.0 contact hours for AOTA affiliated attendees. The CMSC maintains responsibility for this program and its content.
Certificate of Attendance for Other Healthcare Professionals
A Certificate of Attendance will be given upon completion of course requirements enabling participants to register their credit with the appropriate licensing boards or associations. Participants may apply for other accreditations using procedures established by specific organizations.
Disclosure of Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC requires that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC seeks to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC is committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.
The program faculty reported the following relevant financial relationships that they have with ineligible companies:
Patricia Bobryk has disclosed no relevant financial relationships.
Colleen Harris has disclosed the following relevant financial relationships: Consultant: Bristol Myers Squibb, Merck Serono, Novartis, Roche, Sanofi Genzyme.
All of the relevant financial relationships listed for these individuals have been mitigated.
The planners, reviewers, editors, staff, or other members of CMSC who are in a position to control content have disclosed no relevant financial relationships.
Method of Participation / How to Receive Credit
In order to successfully complete this knowledge-based continuing education activity, participants must:
- Read the learning objectives and disclosures.
- Study/view the educational content.
- Complete the online evaluation form.
To complete the evaluation and claim credit, go to www.highmarksce.com/mscare/
- Create a new account or log in with your user name and password*.
- Select the Enduring Materials tab, select the activity from the list and follow the instructions to complete the activity and receive your credit.
*If you forgot your username or password, click on Forgot password. You will receive an email with a link to change your password.
There is no fee to participate in this activity.
Disclosure of Unlabeled Use
CMSC requires faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Commercial Support Acknowledgment
This activity is supported by an educational grants received from Greenwich Biosciences and Sanofi.
CMSC presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC and the commercial supporter(s) assume no liability for the information herein.
If you have any questions about this activity, please contact the CMSC at [email protected].